ToolGen is developing ‘Genomic Cure’ for incurable diseases. They use CRISPR-Cas9 application and deep expertise of therapeutic development to provide novel solutions for both genetic and non-genetic diseases. They have established in vivo and ex vivo therapeutic pipelines.
Contact Details | 8th floor, 172 Magokjungang-ro, Gangseo-gu, Seoul (07789)Tel 02-3660-1300E-mail info@toolgen.com |
---|
Find out more companies
Related products
-
SME
ALTEOGEN Inc.
ALTEOGEN Inc. is a leading bio company whose portfolio includes next-generation biobetters, biosimilars, and proprietary biologics. They are focusing on three cutting-edge areas of the industry – long-acting biobetters, proprietary antibody-drug conjugate (ADC), and antibody biosimilars with high complexity.